SCHEMBL5899491

SCHEMBL5899491

Cc1cc(C)cc(S(=O)(=O)NCC(=O)c2ccc3ccccc3c2)c1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KAT6A Q92794 5/20 0.62
CTSS P25774 1/20 0.48
POLB P06746 1/20 0.47
SMN1; SMN2 Q16637 3/20 0.47
KDM4E B2RXH2 1/20 0.47
HPGD P15428 1/20 0.47
PTPN1 P18031 1/20 0.47
ALDH1A1 P00352 6/20 0.45
ALOX12 P18054 1/20 0.45
NPC1 O15118 1/20 0.45
RAB9A P51151 1/20 0.45
CA12 O43570 3/20 0.44
CA1 P00915 3/20 0.44
CA2 P00918 3/20 0.44
CA9 Q16790 3/20 0.44
LMNA P02545 1/20 0.43
GAA P10253 1/20 0.43
HDAC3 O15379 1/20 0.43
HDAC4 P56524 1/20 0.43
HDAC1 Q13547 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5899462 0.86 KAT6A (0.71) KAT6ACTSSPOLBSMN1; SMN2KDM4E
SCHEMBL5899480 0.85 KAT6A (0.54) KAT6AALDH1A1NPC1RAB9AGAA
SCHEMBL5899477 0.82 KAT6A (0.65) KAT6ACTSSPOLBPTPN1ALDH1A1
SCHEMBL5899421 0.82 KAT6A (0.65) KAT6ACTSSPOLBPTPN1ALDH1A1
SCHEMBL5899507 0.80 KAT6A (0.66) KAT6APOLBSMN1; SMN2ALDH1A1CA12
SCHEMBL5899446 0.79 KAT6A (0.72) KAT6ACTSSPOLBALDH1A1NPC1
SCHEMBL5899485 0.76 KAT6A (0.63) KAT6ASMN1; SMN2KDM4EHPGDPTPN1
SCHEMBL5899429 0.74 KAT6A (0.68) KAT6AHPGDALDH1A1LMNAHDAC8
SCHEMBL16883484 0.74 PTPN1 (0.61) KAT6ASMN1; SMN2KDM4EHPGDPTPN1
SCHEMBL28531984 0.72 ALDH1A1 (0.58) KAT6ASMN1; SMN2HPGDALDH1A1CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060025445-A1 11-Beta HSD1 inhibitors WYETH 2006-02-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060025445-A1 11-Beta HSD1 inhibitors HSD11B1, HSD11B2, HSD3B1 KAT6A 2440/4885CTSS 2191/4885POLB 1440/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.